eupatilin and Brain-Ischemia

eupatilin has been researched along with Brain-Ischemia* in 1 studies

Other Studies

1 other study(ies) available for eupatilin and Brain-Ischemia

ArticleYear
The neuroprotective effect of eupatilin against ischemia/reperfusion-induced delayed neuronal damage in mice.
    European journal of pharmacology, 2012, Aug-15, Volume: 689, Issue:1-3

    Eupatilin, a pharmacologically active flavone derived from the Artemisia plant species, has been reported to have anti-oxidant, anti-inflammatory, anti-allergic, and anti-tumor activities. In the present study, we investigated whether eupatilin exhibits neuroprotective activities against ischemia/reperfusion-induced delayed neuronal injury in mice. Transient global cerebral ischemia was induced in mice by bilateral common carotid artery occlusion (BCCAO) for 15 min followed by reperfusion for 4 days. Eupatilin (1, 3, or 10 mg/kg, p.o.) was administered immediately after the reperfusion. Histochemical studies showed that eupatilin (10 mg/kg) increased the number of viable cells detected by Nissl staining and decreased the number of degenerating neuronal cells detected by Fluoro-Jade B staining in the hippocampal CA1 region. Western blotting indicated that eupatilin further increased the level of Akt phosphorylation at 8h after BCCAO. Furthermore, wortmannin, a phosphatidylinositol 3-kinase inhibitor, attenuated the eupatilin-induced increase of Akt phosphorylation. In addition, wortmannin completely reversed the eupatilin-induced neuroprotective effects observed at 4 days after reperfusion. These findings suggest that eupatilin is a promising therapeutic agent against global cerebral ischemia-induced neuronal damage and that its neuroprotective effects may be mediated in part by increased Akt phosphorylation.

    Topics: Animals; Brain Ischemia; Drugs, Chinese Herbal; Flavonoids; Male; Mice; Neurons; Neuroprotective Agents; Reperfusion Injury; Time Factors

2012